← FDA Drug Approvals (Drugs@FDA)

INVIRASE

NDA · New Drug Application · Sponsor: HOFFMANN LA ROCHE · Approved 1995-12-06

Drug application

FDA Application #

NDA020628

Application type

New Drug Application

Brand name

INVIRASE

Generic name

Saquinavir Mesylate

Active ingredients

SAQUINAVIR MESYLATE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Discontinued

Sponsor

HOFFMANN LA ROCHE

First approval

1995-12-06

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown